Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrin Sealant Grifols in Peripheral Vascular Surgery
NCT01662856Phase 3Completed
- Sponsor
- Grifols
- Start
- Aug 2012
- Primary completion
- Dec 2015
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Phase 3, randomised, single-blind trial of VISTASEAL in hemorrhage (2 arms), sponsored by Grifols. Primary endpoint: Proportion of Subjects Achieving Hemostasis by Four Minutes After Treatment Start. Started Aug 2012; status: completed.
02
Drugs
VISTASEAL
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT01662856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662856.